Abstract
Our aim in this study was to describe the clinical, morphological, and molecular profile of gastrointestinal stromal tumor (GIST) metastatic to bone. We analyzed the morphological, phenotypic, and molecular characteristics of seven cases, and in addition reviewed 17 cases from literature. Sequence analysis of KIT and PDGFRA genes was possible for six cases. For the GIST cases with bone metastasis, the most common primaries were small intestine (29%), stomach (25%), and rectum (21%). Sites of bone metastases were vertebrae (11), pelvis (8), femur (8), ribs (6), humerus (5), skull (3), scapula (1), and mandible (1). The size ranged from 1.5 to 13 cm (median, 3.8 cm). Bone metastases without involvement of any other organ were seen in 17% of the cases and were solitary in 14 (58%). Adjacent soft tissue involvement was present in nearly half of the patients. Bone metastasis was either manifest at the time of diagnosis (28%) or occurred after a mean period of 4.7 years (3 months–20 years). Morphologically, neoplastic cells were spindle in 67%, epithelioid in 13%, and mixed epithelioid and spindle in 20%. CD117, DOG1, and CD34 were positive in 88, 86, and 85% of the cases, respectively. KIT Exon 11 mutations were the most frequent gene alteration (78%), followed by KIT Exon 13 mutations. Of 17 of the cases with available follow-up information, 7 (41%) patients developed bone metastasis under imatinib therapy. Five patients (29%) died of disease within a mean of 17 months. Bone metastases from GIST are usually found in patients with advanced disease and typically present as lytic masses with occasional soft tissue involvement. We could not identify any KIT or PDGFRA alterations predisposing to bone metastasis.
Similar content being viewed by others
References
Weiss SW, Goldblum JR, Enzinger FM (2008) Enzinger and Weiss’ soft tissue tumors, 5th edn. Mosby Elsevier, Philadelphia
Bertulli R, Fumagalli E, Coco P, Messina A, Morosi C, Dileo P, Casali PG (2009) Unusual metastatic sites in gastrointestinal stromal tumor (GIST). J Clin Oncol 27:15s (suppl; abstr 10566)
Schuler M, Zeile M, Pink D, Tunn P, Kretzschmar A, Rau B, P. R (2008) Incidence of bone metastases in GIST: a single center analysis of 307 patients with metastatic disease. J Clin Oncol 26:15s (suppl; abstr 10565)
Burkill GJ, Badran M, Al-Muderis O, Meirion Thomas J, Judson IR, Fisher C, Moskovic EC (2003) Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology 226(2):527–532
Stamatakos M, Douzinas E, Stefanaki C, Safioleas P, Polyzou E, Levidou G, Safioleas M (2009) Gastrointestinal stromal tumor. World J Surg Oncol 7:61. doi:10.1186/1477-7819-7-61
Corless CL (2014) Gastrointestinal stromal tumors: what do we know now? Mod Pathol 27(Suppl 1):S1–16. doi:10.1038/modpathol.2013.173
Maleddu A, Pantaleo MA, Nannini M, Biasco G (2011) The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical setting. J Transl Med 9:75. doi:10.1186/1479-5876-9-75
Lasota J, Corless CL, Heinrich MC, Debiec-Rychter M, Sciot R, Wardelmann E, Merkelbach-Bruse S, Schildhaus HU, Steigen SE, Stachura J, Wozniak A, Antonescu C, Daum O, Martin J, Del Muro JG, Miettinen M (2008) Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases. Mod Pathol 21(4):476–484. doi:10.1038/modpathol.2008.2
Lasota J, Miettinen M (2008) Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours. Histopathology 53(3):245–266. doi:10.1111/j.1365-2559.2008.02977.x
Slimack NP, Liu JC, Koski T, McClendon J Jr, O’Shaughnessy BA (2012) Metastatic gastrointestinal stromal tumor to the thoracic and lumbar spine: first reported case and surgical treatment. Spine J 12(1):e7–12. doi:10.1016/j.spinee.2011.10.037
Policarpio-Nicolas ML, Lal A, Nicolas MM, De Frias DV, Nayar R, Nemcek AL Jr, Mellott AL (2006) Bone metastasis of a gastrointestinal tumor with diagnosis by fine needle aspiration biopsy. Acta Cytol 50(3):354–357
Ozan E, Oztekin O, Alacacioglu A, Aykas A, Postaci H, Adibelli Z Esophageal gastrointestinal stromal tumor with pulmonary and bone metastases. Diagn Interv Radiol 16(3):217–220. doi:10.4261/1305-3825.DIR.1861-08.2
Jati A, Tatli S, Morgan JA, Glickman JN, Demetri GD, Van den Abbele A, Silverman SG (2012) Imaging features of bone metastases in patients with gastrointestinal stromal tumors. Diagn Interv Radiol. doi:10.4261/1305-3825.dir.5179-11.1
Gil-Arnaiz I, Martinez-Trufero J, Pazo-Cid RA, Felipo F, Lecumberri MJ, Calderero V (2009) Skull metastasis from rectal gastrointestinal stromal tumours. Clin Transl Oncol 11(9):625–627
Di Scioscio V, Greco L, Pallotti MC, Pantaleo MA, Maleddu A, Nannini M, Bazzocchi A, Di Battista M, Mandrioli A, Lolli C, Saponara M, Giorgio G, Biasco G, Zompatori M (2011) Three cases of bone metastases in patients with gastrointestinal stromal tumors. Rare Tumors 3(2):e17. doi:10.4081/rt.2011.e17
Chu TYC, Wong CS (2009) Bone metastases from gastrointestinal stromal tumour: correlation with positron emission tomography–computed tomography. J HK Coll Radiol 11:172–175
Chou SQH, Tse KS, Wong WK, Chan SCH (2010) Vulval gastrointestinal stromal tumours with bone metastases. J Hong Kong Col Radiol 13:88–90
Bajel A, Simpson I, Longano A, Roy S, Richardson G (2009) Bone marrow metastasis in gastro-intestinal stromal tumour. Br J Haematol 147(1):2. doi:10.1111/j.1365-2141.2009.07735.x
Abuzakhm SM, Acre-Lara CE, Zhao W, Hitchcock C, Mohamed N, Arbogast D, Shah MH (2011) Unusual metastases of gastrointestinal stromal tumor and genotypic correlates: case report and review of the literature. J Gastrointest Oncol 2:45–49
Baeg MK, Bae SH, Lee KH, Kim J, Park IS, Jin JY Diplopia as a presenting symptom in a gastric gastrointestinal stromal tumor. Jpn J Clin Oncol 41(2):265–268. doi:10.1093/jjco/hyq176
Jain A, Dubashi B, Chandra SS, Halanaik D (2011) Mesentric gastrointestinal stromal tumor with bone metastases. Indian J Cancer 48(3):383–384. doi:10.4103/0019-509X.84934
Tezcan Y, Koc M (2011) Gastrointestinal stromal tumor of the rectum with bone and liver metastasis: a case study. Med Oncol 28(Suppl 1):S204–S206. doi:10.1007/s12032-010-9697-7
Selcukbiricik F, Tural D, Oztürk MA, Dervisoglu D, Sager S, Hiz M, Mandel NM (2012) Gastrointestinal stromal tumor of the rectum with scapular metastasis: a case report. J Med Case Rep 6(145). doi:10.1186/1752-1947-6-145
Steigen SE, Eide TJ (2009) Gastrointestinal stromal tumors (GISTs): a review. APMIS 117(2):73–86. doi:10.1111/j.1600-0463.2008.00020.x
Miettinen M, Sobin LH, Lasota J (2009) Gastrointestinal stromal tumors presenting as omental masses—a clinicopathologic analysis of 95 cases. Am J Surg Pathol 33(9):1267–1275. doi:10.1097/PAS.0b013e3181a13e99
Miettinen M, Makhlouf H, Sobin LH, Lasota J (2006) Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol 30(4):477–489
Miettinen M, Sobin LH, Lasota J (2005) Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29(1):52–68
Miettinen M, Furlong M, Sarlomo-Rikala M, Burke A, Sobin LH, Lasota J (2001) Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol 25(9):1121–1133
DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231(1):51–58
Yoshikawa H, Myoui A, Ochi T, Araki N, Ueda T, Kudawara I, Nakanishi K, Tanaka H, Nakamura H (1999) Bone metastases from soft tissue sarcomas. Semin Musculoskelet Radiol 3(2):183–190. doi:10.1055/s-2008-1080061
Blay JY, Bonvalot S, Casali P, Choi H, Debiec-Richter M, Dei Tos AP, Emile JF, Gronchi A, Hogendoorn PC, Joensuu H, Le Cesne A, McClure J, Maurel J, Nupponen N, Ray-Coquard I, Reichardt P, Sciot R, Stroobants S, van Glabbeke M, van Oosterom A, Demetri GD (2005) Panelists Gcm: consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol 16(4):566–578. doi:10.1093/annonc/mdi127
Aras Y, Akcakaya MO, Unal SN, Bilgic B, Unal OF (2012) Bone marrow necrosis secondary to imatinib usage, mimicking spinal metastasis on magnetic resonance imaging and FDG-PET/CT. J Neurosurg Spine 16(1):57–60. doi:10.3171/2011.9.SPINE11401
Vanel D, Bonvalot S, Pechoux CL, Cioffi A, Domont J, Cesne AL (2007) Imatimid-induced bone marrow necrosis detected on MRI examination and mimicking bone metastases. Skelet Radiol 36(9):895–898. doi:10.1007/s00256-007-0344-0
Reith JD, Goldblum JR, Lyles RH, Weiss SW (2000) Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol 13(5):577–585. doi:10.1038/modpathol.3880099
Yamamoto H, Oda Y, Kawaguchi K, Nakamura N, Takahira T, Tamiya S, Saito T, Oshiro Y, Ohta M, Yao T, Tsuneyoshi M (2004) c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue). Am J Surg Pathol 28(4):479–488
Barros A, Linhares E, Valadao M, Goncalves R, Vilhena B, Gil C, Ramos C (2011) Extragastrointestinal stromal tumors (EGIST): a series of case reports. Hepato-Gastroenterology 58(107–108):865–868
Miettinen M, Lasota J (2011) Histopathology of gastrointestinal stromal tumor. J Surg Oncol 104(8):865–873. doi:10.1002/jso.21945
Molina I, Seamon LG, Copeland LJ, Suarez A (2009) Reclassification of leiomyosarcoma as an extra-gastrointestinal stromal tumor of the gynecologic tract. Int J Gynecol Pathol 28(5):458–463. doi:10.1097/PGP.0b013e31819c7fc1
Foster R, Solano S, Mahoney J, Fuller A, Oliva E, Seiden MV (2006) Reclassification of a tubal leiomyosarcoma as an eGIST by molecular evaluation of c-KIT. Gynecol Oncol 101(2):363–366. doi:10.1016/j.ygyno.2005.12.022
Weppler EH, Gaertner EM (2005) Malignant extragastrointestinal stromal tumor presenting as a vaginal mass: report of an unusual case with literature review. Int J Gynecol Cancer 15(6):1169–1172. doi:10.1111/j.1525-1438.2005.00269.x
Lam MM, Corless CL, Goldblum JR, Heinrich MC, Downs-Kelly E, Rubin BP (2006) Extragastrointestinal stromal tumors presenting as vulvovaginal/rectovaginal septal masses: a diagnostic pitfall. Int J Gynecol Pathol 25(3):288–292. doi:10.1097/01.pgp.0000215291.22867.18
De Chiara A, De Rosa V, Lastoria S, Franco R, Botti G, Iaffaioli VR, Apice G (2006) Primary gastrointestinal stromal tumor of the liver with lung metastases successfully treated with STI-571 (imatinib mesylate). Front Biosci 11:498–501
Hu X, Forster J, Damjanov I (2003) Primary malignant gastrointestinal stromal tumor of the liver. Arch Pathol Lab Med 127(12):1606–1608. doi:10.1043/1543-2165(2003)127<1606:PMGSTO>2.0.CO;2
Luo XL, Liu D, Yang JJ, Zheng MW, Zhang J, Zhou XD (2009) Primary gastrointestinal stromal tumor of the liver: a case report. World J Gastroenterol 15(29):3704–3707
Ochiai T, Sonoyama T, Kikuchi S, Ikoma H, Kubota T, Nakanishi M, Ichikawa D, Kikuchi S, Fujiwara H, Okamoto K, Sakakura C, Kokuba Y, Taniguchi H, Otsuji E (2009) Primary large gastrointestinal stromal tumor of the liver: report of a case. Surg Today 39(7):633–636. doi:10.1007/s00595-008-3885-5
Yamamoto H, Miyamoto Y, Nishihara Y, Kojima A, Imamura M, Kishikawa K, Takase Y, Ario K, Oda Y, Tsuneyoshi M (2010) Primary gastrointestinal stromal tumor of the liver with PDGFRA gene mutation. Hum Pathol 41(4):605–609. doi:10.1016/j.humpath.2009.09.016
Merten L, Agaimy A, Moskalev EA, Giedl J, Kayser C, Geddert H, Schaefer IM, Cameron S, Werner M, Strobel P, Hartmann A, Haller F (2016) Inactivating mutations of RB1 and TP53 correlate with sarcomatous histomorphology and metastasis/recurrence in gastrointestinal stromal tumors. Am J Clin Pathol 146(6):718–726. doi:10.1093/ajcp/aqw193
Wong NA (2011) Gastrointestinal stromal tumours—an update for histopathologists. Histopathology 59(5):807–821. doi:10.1111/j.1365-2559.2011.03812.x
Miettinen M, Lasota J (2005) KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol 13(3):205–220
Miettinen M, Wang ZF, Lasota J (2009) DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Am J Surg Pathol 33(9):1401–1408. doi:10.1097/PAS.0b013e3181a90e1a
Corless CL, McGreevey L, Town A, Schroeder A, Bainbridge T, Harrell P, Fletcher JA, Heinrich MC (2004) KIT gene deletions at the intron 10-exon 11 boundary in GI stromal tumors. J Mol Diagn 6(4):366–370. doi:10.1016/S1525-1578(10)60533-8
Lee JR, Joshi V, Griffin JW Jr, Lasota J, Miettinen M (2001) Gastrointestinal autonomic nerve tumor: immunohistochemical and molecular identity with gastrointestinal stromal tumor. Am J Surg Pathol 25(8):979–987
Heinrich MC, Maki RG, Corless CL, Antonescu CR, Harlow A, Griffith D, Town A, McKinley A, Ou WB, Fletcher JA, Fletcher CD, Huang X, Cohen DP, Baum CM, Demetri GD (2008) Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor. J Clin Oncol 26(33):5352–5359. doi:10.1200/JCO.2007.15.7461
Martin J, Poveda A, Llombart-Bosch A, Ramos R, Lopez-Guerrero JA, Garcia del Muro J, Maurel J, Calabuig S, Gutierrez A, Gonzalez de Sande JL, Martinez J, De Juan A, Lainez N, Losa F, Alija V, Escudero P, Casado A, Garcia P, Blanco R, Buesa JM (2005) Spanish Group for Sarcoma R: deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS). J Clin Oncol 23(25):6190–6198. doi:10.1200/JCO.2005.19.554
Ma Y, Cunningham ME, Wang X, Ghosh I, Regan L, Longley BJ (1999) Inhibition of spontaneous receptor phosphorylation by residues in a putative alpha-helix in the KIT intracellular juxtamembrane region. J Biol Chem 274(19):13399–13402
Antonescu CR, Sommer G, Sarran L, Tschernyavsky SJ, Riedel E, Woodruff JM, Robson M, Maki R, Brennan MF, Ladanyi M, DeMatteo RP, Besmer P (2003) Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors. Clin Cancer Res 9(9):3329–3337
Kontogianni-Katsarou K, Dimitriadis E, Lariou C, Kairi-Vassilatou E, Pandis N, Kondi-Paphiti A (2008) KIT exon 11 codon 557/558 deletion/insertion mutations define a subset of gastrointestinal stromal tumors with malignant potential. World J Gastroenterol 14(12):1891–1897
Joensuu H, Rutkowski P, Nishida T, Steigen SE, Brabec P, Plank L, Nilsson B, Braconi C, Bordoni A, Magnusson MK, Sufliarsky J, Federico M, Jonasson JG, Hostein I, Bringuier PP, Emile JF (2015) KIT and PDGFRA mutations and the risk of GI stromal tumor recurrence. J Clin Oncol 33(6):634–642. doi:10.1200/JCO.2014.57.4970
Patrikidou A, Domont J, Chabaud S, Ray-Coquard I, Coindre JM, Bui-Nguyen B, Adenis A, Rios M, Bertucci F, Duffaud F, Chevreau C, Cupissol D, Perol D, Emile JF, Blay JY, Le Cesne A, French Sarcoma G (2016) Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group. Eur J Cancer 52:173–180. doi:10.1016/j.ejca.2015.10.069
Kumari N, Priyaa V, Shukla P, Kumar A, Aggarwal R, Krishnani N (2016) Gastrointestinal stromal tumor: genotype frequency and prognostic relevance. Appl Immunohistochem Mol Morphol. doi:10.1097/PAI.0000000000000395
Wang HC, Li TY, Chao YJ, Hou YC, Hsueh YS, Hsu KH, Shan YS (2016) KIT exon 11 codons 557-558 deletion mutation promotes liver metastasis through the CXCL12/CXCR4 axis in gastrointestinal stromal tumors. Clin Cancer Res 22(14):3477–3487. doi:10.1158/1078-0432.CCR-15-2748
Rossle M, Hirschmann A, Diebold J (2011) Mutational spectrum and therapy response of metastasized GIST in Central Switzerland—a population-based study. Eur J Cancer 47(9):1305–1311. doi:10.1016/j.ejca.2011.01.012
Antonescu CR, Besmer P, Guo T, Arkun K, Hom G, Koryotowski B, Leversha MA, Jeffrey PD, Desantis D, Singer S, Brennan MF, Maki RG, DeMatteo RP (2005) Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. Clin Cancer Res 11(11):4182–4190. doi:10.1158/1078-0432.CCR-04-2245
Wardelmann E, Merkelbach-Bruse S, Pauls K, Thomas N, Schildhaus HU, Heinicke T, Speidel N, Pietsch T, Buettner R, Pink D, Reichardt P, Hohenberger P (2006) Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate. Clin Cancer Res 12(6):1743–1749. doi:10.1158/1078-0432.CCR-05-1211
Saponara M, Urbini M, Astolfi A, Indio V, Ercolani G, Del Gaudio M, Santini D, Pirini MG, Fiorentino M, Nannini M, Lolli C, Mandrioli A, Gatto L, Brandi G, Biasco G, Pinna AD, Pantaleo MA (2015) Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRalpha genotype evaluated by next generation sequencing (NGS). Oncotarget 6(39):42243–42257. doi:10.18632/oncotarget.6278
Acknowledgements
The molecular studies and DOG1 staining were performed in Ankara University, Department of Pathology, and supported by an institutional contribution of TUBITAK (project no.: 209S109).
This study presented as poster at the USCAP Meeting, Baltimore, USA, 2013.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
ESM 1
(DOCX 22 kb)
Rights and permissions
About this article
Cite this article
Kosemehmetoglu, K., Kaygusuz, G., Fritchie, K. et al. Clinical and pathological characteristics of gastrointestinal stromal tumor (GIST) metastatic to bone. Virchows Arch 471, 77–90 (2017). https://doi.org/10.1007/s00428-017-2138-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-017-2138-7